LAB vs PLD · rev $174.4M vs P/E 27, rev $8.79B
Standard Biotools Inc (LAB) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
LAB currently screens at market cap $317.1M. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the LAB and PLD stock pages for the full models.
Not investment advice.